{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T13:33:07Z","timestamp":1791379987804,"version":"4.3.3"},"reference-count":43,"publisher":"Oxford University Press (OUP)","issue":"4","license":[{"start":{"date-parts":[[2017,8,1]],"date-time":"2017-08-01T00:00:00Z","timestamp":1501545600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2017,8,15]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>Seasonal influenza viruses are a common cause of acute respiratory illness worldwide and generate a significant socioeconomic burden. Influenza viruses mutate rapidly, necessitating annual vaccine reformulation because traditional vaccines do not typically induce broad-spectrum immunity. In addition to seasonal infections, emerging pandemic influenza viruses present a continued threat to global public health. Pandemic influenza viruses have consistently higher attack rates and are typically associated with greater mortality compared with seasonal strains. Ongoing strategies to improve vaccine efficacy typically focus on providing broad-spectrum immunity; although B and T cells can mediate heterosubtypic responses, typical vaccine development will augment either humoral or cellular immunity. However, multipronged approaches that target several Ags may limit the generation of viral escape mutants. There are few vaccine platforms that can deliver multiple Ags and generate robust cellular and humoral immunity. In this article, we describe a novel vaccination strategy, tested preclinically in mice, for the delivery of novel bivalent viral-vectored vaccines. We show this strategy elicits potent T cell responses toward highly conserved internal Ags while simultaneously inducing high levels of Abs toward hemagglutinin. Importantly, these humoral responses generate long-lived plasma cells and generate Abs capable of neutralizing variant hemagglutinin-expressing pseudotyped lentiviruses. Significantly, these novel viral-vectored vaccines induce strong immune responses capable of conferring protection in a stringent influenza A virus challenge. Thus, this vaccination regimen induces lasting efficacy toward influenza. Importantly, the simultaneous delivery of dual Ags may alleviate the selective pressure that is thought to potentiate antigenic diversity in avian influenza viruses.<\/jats:p>","DOI":"10.4049\/jimmunol.1600939","type":"journal-article","created":{"date-parts":[[2017,7,20]],"date-time":"2017-07-20T00:30:24Z","timestamp":1500510624000},"page":"1333-1341","source":"Crossref","is-referenced-by-count":18,"title":["Novel Bivalent Viral-Vectored Vaccines Induce Potent Humoral and Cellular Immune Responses Conferring Protection against Stringent Influenza A Virus Challenge"],"prefix":"10.1093","volume":"199","author":[{"given":"Claire M","family":"Tully","sequence":"first","affiliation":[{"name":"Jenner Institute, University of Oxford , Oxford OX3 7DQ,","place":["United Kingdom"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4404-0229","authenticated-orcid":false,"given":"Senthil","family":"Chinnakannan","sequence":"additional","affiliation":[{"name":"Peter Medawar Building for Pathogen Research, University of Oxford , Oxford OX1 3SY,","place":["United Kingdom"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caitlin E","family":"Mullarkey","sequence":"additional","affiliation":[{"name":"Department of Microbiology, Icahn School of Medicine at Mount Sinai , New York, NY 10029"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marta","family":"Ulaszewska","sequence":"additional","affiliation":[{"name":"Jenner Institute, University of Oxford , Oxford OX3 7DQ,","place":["United Kingdom"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4973-1520","authenticated-orcid":false,"given":"Francesca","family":"Ferrara","sequence":"additional","affiliation":[{"name":"Pseudotype Unit, School of Pharmacy, University of Kent , Chatham Maritime, Kent ME4 4TB,","place":["United Kingdom"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nigel","family":"Temperton","sequence":"additional","affiliation":[{"name":"Pseudotype Unit, School of Pharmacy, University of Kent , Chatham Maritime, Kent ME4 4TB,","place":["United Kingdom"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6823-9750","authenticated-orcid":false,"given":"Sarah C","family":"Gilbert","sequence":"additional","affiliation":[{"name":"Jenner Institute, University of Oxford , Oxford OX3 7DQ,","place":["United Kingdom"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7711-897X","authenticated-orcid":false,"given":"Teresa","family":"Lambe","sequence":"additional","affiliation":[{"name":"Jenner Institute, University of Oxford , Oxford OX3 7DQ,","place":["United Kingdom"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2017,8,15]]},"reference":[{"key":"2025030614242165200_r1","doi-asserted-by":"crossref","first-page":"8671","DOI":"10.1128\/JVI.01034-15","article-title":"Epidemiology, evolution, and recent outbreaks of avian influenza virus in China","volume":"89","author":"Su","year":"2015","journal-title":"J. Virol."},{"key":"2025030614242165200_r2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/14760584.2017.1333907","article-title":"Tackling a novel lethal virus: a focus on H7N9 vaccine development","volume":"16","author":"Isakova-Sivak","year":"2017","journal-title":"Expert Rev. Vaccines"},{"key":"2025030614242165200_r3","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.15585\/mmwr.mm6549a2","article-title":"Assessing change in avian influenza A(H7N9) virus infections during the fourth epidemic - China, September 2015\u2013August 2016","volume":"65","author":"Xiang","year":"2016","journal-title":"MMWR Morb. Mortal. Wkly. Rep."},{"key":"2025030614242165200_r4","first-page":"725","article-title":"Vaccination against influenza","volume":"8","author":"Francis","year":"1953","journal-title":"Bull. World Health Organ."},{"key":"2025030614242165200_r5","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1001\/jama.1962.03050400013003","article-title":"Current knowledge of influenza vaccine","volume":"182","author":"Davenport","year":"1962","journal-title":"JAMA"},{"key":"2025030614242165200_r6","first-page":"1","article-title":"Prevention and control of influenza with vaccines: recommendations of the Advisory Committee on Immunization Practices (ACIP), 2010. [Published erratum appears in 2010 MMWR Recomm. Rep. 59: 993; 59: 1147]","volume":"59","author":"Fiore","year":"2010","journal-title":"MMWR. Recomm. Rep."},{"key":"2025030614242165200_r7","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1056\/NEJMoa0808652","article-title":"Comparative efficacy of inactivated and live attenuated influenza vaccines","volume":"361","author":"Monto","year":"2009","journal-title":"N. Engl. J. Med."},{"key":"2025030614242165200_r8","doi-asserted-by":"crossref","first-page":"2513","DOI":"10.1056\/NEJMoa061850","article-title":"Prevention of antigenically drifted influenza by inactivated and live attenuated vaccines","volume":"355","author":"Ohmit","year":"2006","journal-title":"N. Engl. J. Med."},{"key":"2025030614242165200_r9","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1111\/j.0105-2896.2006.00427.x","article-title":"Foxp3+ CD25+ CD4+ natural regulatory T cells in dominant self-tolerance and autoimmune disease","volume":"212","author":"Sakaguchi","year":"2006","journal-title":"Immunol. Rev."},{"key":"2025030614242165200_r10","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1126\/science.aac7263","article-title":"A stable trimeric influenza hemagglutinin stem as a broadly protective immunogen","volume":"349","author":"Impagliazzo","year":"2015","journal-title":"Science"},{"key":"2025030614242165200_r11","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1038\/nm.3927","article-title":"Hemagglutinin-stem nanoparticles generate heterosubtypic influenza protection","volume":"21","author":"Yassine","year":"2015","journal-title":"Nat. Med."},{"key":"2025030614242165200_r12","doi-asserted-by":"crossref","first-page":"3738","DOI":"10.4049\/jimmunol.1003783","article-title":"Combining liver- and blood-stage malaria viral-vectored vaccines: investigating mechanisms of CD8+ T cell interference","volume":"187","author":"Forbes","year":"2011","journal-title":"J. Immunol."},{"key":"2025030614242165200_r13","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1038\/mt.2013.284","article-title":"Clinical assessment of a novel recombinant simian adenovirus ChAdOx1 as a vectored vaccine expressing conserved influenza A antigens","volume":"22","author":"Antrobus","year":"2013","journal-title":"Mol. Ther."},{"key":"2025030614242165200_r14","doi-asserted-by":"crossref","first-page":"1940","DOI":"10.1002\/eji.201242922","article-title":"Improved adjuvanting of seasonal influenza vaccines: preclinical studies of MVA-NP+M1 coadministration with inactivated influenza vaccine","volume":"43","author":"Mullarkey","year":"2013","journal-title":"Eur. J. Immunol."},{"key":"2025030614242165200_r15","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1084\/jem.170.1.279","article-title":"Identical peptides recognized by MHC class I- and II-restricted T cells","volume":"170","author":"Perkins","year":"1989","journal-title":"J. Exp. Med."},{"key":"2025030614242165200_r16","doi-asserted-by":"crossref","first-page":"15987","DOI":"10.1073\/pnas.0607564103","article-title":"Protective immunity to lethal challenge of the 1918 pandemic influenza virus by vaccination","volume":"103","author":"Kong","year":"2006","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"2025030614242165200_r17","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.vaccine.2007.10.064","article-title":"Development and characterization of a standardized ELISA including a reference serum on each plate to detect antibodies induced by experimental malaria vaccines","volume":"26","author":"Miura","year":"2008","journal-title":"Vaccine"},{"key":"2025030614242165200_r18","doi-asserted-by":"crossref","first-page":"2602","DOI":"10.4049\/jimmunol.1101004","article-title":"The requirement for potent adjuvants to enhance the immunogenicity and protective efficacy of protein vaccines can be overcome by prior immunization with a recombinant adenovirus","volume":"187","author":"de Cassan","year":"2011","journal-title":"J. Immunol."},{"key":"2025030614242165200_r19","doi-asserted-by":"crossref","first-page":"7167","DOI":"10.1016\/j.vaccine.2010.08.068","article-title":"Tailoring subunit vaccine immunogenicity: maximizing antibody and T cell responses by using combinations of adenovirus, poxvirus and protein-adjuvant vaccines against Plasmodium falciparum MSP1","volume":"28","author":"Douglas","year":"2010","journal-title":"Vaccine"},{"key":"2025030614242165200_r20","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.vaccine.2015.11.028","article-title":"Enhancing cellular immunogenicity of MVA-vectored vaccines by utilizing the F11L endogenous promoter","volume":"34","author":"Alharbi","year":"2016","journal-title":"Vaccine"},{"key":"2025030614242165200_r21","doi-asserted-by":"crossref","first-page":"78","DOI":"10.4161\/hv.6.1.10116","article-title":"Prime-boost vectored malaria vaccines: progress and prospects","volume":"6","author":"Hill","year":"2010","journal-title":"Hum. Vaccin."},{"key":"2025030614242165200_r22","article-title":"A monovalent chimpanzee adenovirus Ebola vaccine - preliminary report","volume-title":"N. Engl. J. Med.","author":"Rampling","year":"2015"},{"key":"2025030614242165200_r23","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1038\/40540","article-title":"Lifetime of plasma cells in the bone marrow","volume":"388","author":"Manz","year":"1997","journal-title":"Nature"},{"key":"2025030614242165200_r24","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/S1074-7613(00)80541-5","article-title":"Humoral immunity due to long-lived plasma cells","volume":"8","author":"Slifka","year":"1998","journal-title":"Immunity"},{"key":"2025030614242165200_r25","doi-asserted-by":"crossref","first-page":"3976","DOI":"10.1128\/JVI.03095-13","article-title":"Divergent H7 immunogens offer protection from H7N9 virus challenge","volume":"88","author":"Krammer","year":"2014","journal-title":"J. Virol."},{"key":"2025030614242165200_r26","doi-asserted-by":"crossref","first-page":"1889","DOI":"10.1016\/j.vaccine.2009.01.116","article-title":"A phase I clinical trial of a PER.C6 cell grown influenza H7 virus vaccine","volume":"27","author":"Cox","year":"2009","journal-title":"Vaccine"},{"key":"2025030614242165200_r27","doi-asserted-by":"crossref","first-page":"e49704","DOI":"10.1371\/journal.pone.0049704","article-title":"A randomized clinical trial of an inactivated avian influenza A (H7N7) vaccine","volume":"7","author":"Couch","year":"2012","journal-title":"PLoS One"},{"key":"2025030614242165200_r28","doi-asserted-by":"crossref","first-page":"234ra55","DOI":"10.1126\/scitranslmed.3008761","article-title":"A cell culture-derived MF59-adjuvanted pandemic A\/H7N9 vaccine is immunogenic in adults","volume":"6","author":"Bart","year":"2014","journal-title":"Sci. Transl. Med."},{"key":"2025030614242165200_r29","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1016\/S0264-410X(99)00334-5","article-title":"Evaluation of trivalent, live, cold-adapted (CAIV-T) and inactivated (TIV) influenza vaccines in prevention of virus infection and illness following challenge of adults with wild-type influenza A (H1N1), A (H3N2), and B viruses","volume":"18","author":"Treanor","year":"1999","journal-title":"Vaccine"},{"key":"2025030614242165200_r30","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1001\/jama.282.2.137","article-title":"Effectiveness of live, attenuated intranasal influenza virus vaccine in healthy, working adults: a randomized controlled trial","volume":"282","author":"Nichol","year":"1999","journal-title":"JAMA"},{"key":"2025030614242165200_r31","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/S1473-3099(15)00378-3","article-title":"H7N9 live attenuated influenza vaccine in healthy adults: a randomised, double-blind, placebo-controlled, phase 1 trial","volume":"16","author":"Rudenko","year":"2016","journal-title":"Lancet Infect. Dis."},{"key":"2025030614242165200_r32","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1056\/NEJM198307073090103","article-title":"Cytotoxic T-cell immunity to influenza","volume":"309","author":"McMichael","year":"1983","journal-title":"N. Engl. J. Med."},{"key":"2025030614242165200_r33","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1038\/nm.3350","article-title":"Cellular immune correlates of protection against symptomatic pandemic influenza","volume":"19","author":"Sridhar","year":"2013","journal-title":"Nat. Med."},{"key":"2025030614242165200_r34","doi-asserted-by":"crossref","first-page":"6512","DOI":"10.1016\/j.vaccine.2009.08.053","article-title":"Vaccination focusing immunity on conserved antigens protects mice and ferrets against virulent H1N1 and H5N1 influenza A viruses","volume":"27","author":"Price","year":"2009","journal-title":"Vaccine"},{"key":"2025030614242165200_r35","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1038\/nm.2612","article-title":"Preexisting influenza-specific CD4+ T cells correlate with disease protection against influenza challenge in humans","volume":"18","author":"Wilkinson","year":"2012","journal-title":"Nat. Med."},{"key":"2025030614242165200_r36","doi-asserted-by":"crossref","first-page":"1422","DOI":"10.1164\/rccm.201411-1988OC","article-title":"Natural T cell-mediated protection against seasonal and pandemic influenza. results of the Flu Watch cohort study","volume":"191","author":"Hayward","year":"2015","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"2025030614242165200_r37","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/cid\/ciq015","article-title":"Potent CD8+ T-cell immunogenicity in humans of a novel heterosubtypic influenza A vaccine, MVA-NP+M1","volume":"52","author":"Berthoud","year":"2011","journal-title":"Clin. Infect. Dis."},{"key":"2025030614242165200_r38","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.4049\/jimmunol.1201455","article-title":"Assessment of immune interference, antagonism, and diversion following human immunization with biallelic blood-stage malaria viral-vectored vaccines and controlled malaria infection","volume":"190","author":"Elias","year":"2013","journal-title":"J. Immunol."},{"key":"2025030614242165200_r39","doi-asserted-by":"crossref","first-page":"2187","DOI":"10.1084\/jem.20070489","article-title":"Cross-competition of CD8+ T cells shapes the immunodominance hierarchy during boost vaccination","volume":"204","author":"Kastenmuller","year":"2007","journal-title":"J. Exp. Med."},{"key":"2025030614242165200_r40","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1084\/jem.192.8.1105","article-title":"T cells compete for access to antigen-bearing antigen-presenting cells","volume":"192","author":"Kedl","year":"2000","journal-title":"J. Exp. Med."},{"key":"2025030614242165200_r41","doi-asserted-by":"crossref","first-page":"8743","DOI":"10.1128\/JVI.00604-10","article-title":"Immediate-early expression of a recombinant antigen by modified vaccinia virus ankara breaks the immunodominance of strong vector-specific B8R antigen in acute and memory CD8 T-cell responses","volume":"84","author":"Baur","year":"2010","journal-title":"J. Virol."},{"key":"2025030614242165200_r42","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1038\/mt.2013.162","article-title":"Coadministration of seasonal influenza vaccine and MVA-NP+M1 simultaneously achieves potent humoral and cell-mediated responses","volume":"22","author":"Antrobus","year":"2014","journal-title":"Mol. Ther."},{"key":"2025030614242165200_r43","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1073\/pnas.1422456112","article-title":"Evolution of the H9N2 influenza genotype that facilitated the genesis of the novel H7N9 virus","volume":"112","author":"Pu","year":"2015","journal-title":"Proc. Natl. Acad. Sci. USA"}],"container-title":["The Journal of Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/jimmunol\/article-pdf\/199\/4\/1333\/61520954\/ji1600939.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jimmunol\/article-pdf\/199\/4\/1333\/61520954\/ji1600939.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,6]],"date-time":"2025-03-06T16:19:15Z","timestamp":1741277955000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jimmunol\/article\/199\/4\/1333\/7964757"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,8]]},"references-count":43,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2017,8,15]]}},"URL":"https:\/\/doi.org\/10.4049\/jimmunol.1600939","relation":{},"ISSN":["0022-1767","1550-6606"],"issn-type":[{"value":"0022-1767","type":"print"},{"value":"1550-6606","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2017,8]]},"published":{"date-parts":[[2017,8]]}}}